14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Diabetes Mellitus, Type 1 in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alaeddine, LM | 1 |
| Harb, F | 1 |
| Hamza, M | 1 |
| Dia, B | 1 |
| Mogharbil, N | 1 |
| Azar, NS | 1 |
| Noureldein, MH | 1 |
| El Khoury, M | 1 |
| Sabra, R | 1 |
| Eid, AA | 1 |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Pharmacological regulation of cytochrome P450 metabolites of arachidonic acid attenuates cardiac injury in diabetic rats.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Cardiomyopathies; Cytochrome P-450 Enzyme Sy | 2021 |